2 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Common Variable Immunodeficiency: new trials by email Literature Review of Common Variable Immunodeficiency trials Research Report on Common Variable Immunodeficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 and 3 Placebo Controlled & Long-term Extension Study of Rilzabrutinib in Adults With iCVID to Evaluate Efficacy, Safety, and Tolerability rilzabrutinib, placebo - Immunodeficiency Common Variable | Phase 2 / Phase 3 | Not yet recruiting | Sanofi | 96 | 2026-11-09 | 2026-11-06 |
| IVIG Boya: Safety, Efficacy, and Pharmacokinetics Boya IVIG - Primary Immunodeficiency Disease | Phase 3 | Not yet recruiting | Azidus Brasil | 50 | 2026-09-01 | 2026-06-03 |
Bruton type agammaglobulinemia (1) · Primary Immunodeficiency Diseases (1)
Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1)
Immunoglobulins, Intravenous (1)
Azidus Brasil (1) · Sanofi (1)
Luciana Ferrara (1)